Phathom Pharmaceuticals, Inc. PHAT Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Phathom Pharmaceuticals, Inc.’s reported figures.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s free cash flow?
- Phathom Pharmaceuticals, Inc. (PHAT) reported free cash flow of -$15.71M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s free cash flow changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s free cash flow increased by 81.5% year-over-year, from -$84.95M to -$15.71M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s free cash flow has grown at a 2.9% compound annual growth rate (CAGR), from -$148.79M to -$167M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.